Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 525-530

  Fernández Hidalgo, Nuria ^a,b   Gavaldà, Joan ^a,b   Almirante, Benito ^a,b   Martín, María Teresa ^a,b   Onrubia, Pedro López ^a,b   Gomis, Xavier ^a,b   Pahissa, Albert ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Animal; Methicillin resistant; Methicillin susceptible; Stability

Indexed keywords

CIPROFLOXACIN; GENTAMICIN; LINEZOLID; SILICONE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CATHETER INFECTION; CATHETERIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG STABILITY; EXPERIMENTAL RABBIT; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBILITY STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DISINFECTION; EQUIPMENT AND SUPPLIES; HUMANS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77950327390     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp499     Document Type: Article

References (23)

1. Fernández-Hidalgo N, Almirante B, Calleja R et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 2006; 57: 1172-80.
2. Poole CV, Carlton D, Bimbo L et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19: 1237-44.
3. Maya ID, Carlton D, Estrada E et al. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with antibiotic lock: a quality improvement report. Am J Kidney Dis 2007; 50: 289-95.
4. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteraemia in patients with Hickman catheters. Am J Med 1990; 89: 137-41.
5. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
6. Capdevila JA, Gavaldà J, Fortea J et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001; 7: 206-12.
7. Giacometti A, Cirioni O, Ghiselli R et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49: 4042-5.
8. Fortún J, Grill F, Martín-Dávila P et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58: 816-21.
9. Gudiol F, Aguado JM, Pascual A et al. [Consensus document for the treatment of bacteremia and endocarditis by methicillin-resistant Staphylococcus aureus]. Enferm Infecc Microbiol Clin 2009; 27: 105-15.
10. Bailey E, Berry N, Cheesbrough JS. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 2002; 50: 615-7.
11. Benoit JL, Carandang G, Sitrin M et al. Intraluminal antibiotic treatment for central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286-8.
12. Krishnasami Z, Carlton D, Bimbo L et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136-42.
13. Anhalt JP. Antimicrobial assays. In: Washington JA, ed. Laboratory Procedures in Clinical Microbiology. New York: Springer-Verlag, 1985; 691-729.
14. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A8. CLSI, Wayne, PA, USA, 2009.
15. Kagamata-Kiyoura Y, Abe S, Yamaguchi H et al. Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate. J Infect Chemother 2003; 9: 215-20.
16. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
17. Ghiselli R, Giacometti A, Cirioni O et al. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. JPEN J Parenter Enteral Nutr 2007; 31: 463-8.
18. Cirioni O, Giacometti A, Ghiselli R et al. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 2006; 193: 180-6.
19. Ceri H, Olson ME, Stremick C et al. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-6.
20. Bookstaver PB, Williamson JC, Tucker BK et al. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 2009; 43: 210-9.
21. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2005; 49: 2467-73.
22. Costerton JW, Stewart PS, Greengerg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
23. Shanks RMQ, Donegan NP, Graber ML et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73: 4596-606.